Lv21
140 积分 2023-09-11 加入
Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation
2小时前
已完结
B Cell–Directed Therapy in Autoimmunity
11个月前
已完结
Longitudinal Immune Cell Profiling in Patients With Early Systemic Lupus Erythematosus
1年前
已完结
Hope for patients with neuromyelitis optica spectrum disorders - from mechanisms to trials
1年前
已完结
CD56 Has a Critical Role in Regulating Multiple Myeloma Cell Growth and Response to Therapies
1年前
已关闭
The immunology of multiple sclerosis
1年前
已完结
CD19-targeted chimeric antigen receptor T-cell therapy in patients with concurrent B-cell Non-Hodgkin lymphoma and rheumatic autoimmune diseases: a propensity score matching study
1年前
已完结
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
1年前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
1年前
已完结
Production of functional plasmacytoid dendritic cells – targeted chimeric antigen receptor T cells from patients with immune-mediated inflammatory diseases
1年前
已完结
皖公网安备34019202002308
